Marine-Derived Angiogenesis Inhibitors for Cancer Therapy

Angiogenesis inhibitors have been successfully used for cancer therapy in the clinic. Many marine-derived natural products and their analogues have been reported to show antiangiogenic activities. Compared with the drugs in the clinic, these agents display interesting characteristics, including dive...

Full description

Bibliographic Details
Main Authors: Ying-Qing Wang, Ze-Hong Miao
Format: Article
Language:English
Published: MDPI AG 2013-03-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/11/3/903
_version_ 1811263935833178112
author Ying-Qing Wang
Ze-Hong Miao
author_facet Ying-Qing Wang
Ze-Hong Miao
author_sort Ying-Qing Wang
collection DOAJ
description Angiogenesis inhibitors have been successfully used for cancer therapy in the clinic. Many marine-derived natural products and their analogues have been reported to show antiangiogenic activities. Compared with the drugs in the clinic, these agents display interesting characteristics, including diverse sources, unique chemical structures, special modes of action, and distinct activity and toxicity profiles. This review will first provide an overview of the current marine-derived angiogenesis inhibitors based on their primary targets and/or mechanisms of action. Then, the marine-derived antiangiogenic protein kinase inhibitors will be focused on. And finally, the clinical trials of the marine-derived antiangiogenic agents will be discussed, with special emphasis on their application potentials, problems and possible coping strategies in their future development as anticancer drugs.
first_indexed 2024-04-12T19:54:06Z
format Article
id doaj.art-32c046ccea194c2a8bddf5cf5fb6439b
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-12T19:54:06Z
publishDate 2013-03-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-32c046ccea194c2a8bddf5cf5fb6439b2022-12-22T03:18:42ZengMDPI AGMarine Drugs1660-33972013-03-0111390393310.3390/md11030903Marine-Derived Angiogenesis Inhibitors for Cancer TherapyYing-Qing WangZe-Hong MiaoAngiogenesis inhibitors have been successfully used for cancer therapy in the clinic. Many marine-derived natural products and their analogues have been reported to show antiangiogenic activities. Compared with the drugs in the clinic, these agents display interesting characteristics, including diverse sources, unique chemical structures, special modes of action, and distinct activity and toxicity profiles. This review will first provide an overview of the current marine-derived angiogenesis inhibitors based on their primary targets and/or mechanisms of action. Then, the marine-derived antiangiogenic protein kinase inhibitors will be focused on. And finally, the clinical trials of the marine-derived antiangiogenic agents will be discussed, with special emphasis on their application potentials, problems and possible coping strategies in their future development as anticancer drugs.http://www.mdpi.com/1660-3397/11/3/903marine natural productsangiogenesisprotein kinasecancer therapy
spellingShingle Ying-Qing Wang
Ze-Hong Miao
Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
Marine Drugs
marine natural products
angiogenesis
protein kinase
cancer therapy
title Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
title_full Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
title_fullStr Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
title_full_unstemmed Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
title_short Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
title_sort marine derived angiogenesis inhibitors for cancer therapy
topic marine natural products
angiogenesis
protein kinase
cancer therapy
url http://www.mdpi.com/1660-3397/11/3/903
work_keys_str_mv AT yingqingwang marinederivedangiogenesisinhibitorsforcancertherapy
AT zehongmiao marinederivedangiogenesisinhibitorsforcancertherapy